Molecular Response (MRL) Launches TargetX™ Platform for Rapid Discovery & Validation of New Oncology Targets
4/8/2013 9:50:01 AM
More...
|
Molecular Response (MRL) Opens Access to Genomic DNA for Research
4/18/2012 10:45:44 PM
More...
|
Transparent Inc. of Japan, and Molecular Response (MRL) Sign Key Collaboration and Supply Agreement to Launch Novel Ex-Vivo 3D Cell Culture System Focused on Oncology Applications
3/29/2012 6:49:17 AM
More...
|
Transparent Inc., and Molecular Response (MRL) Sign Key Collaboration and Supply Agreement to Launch Novel Ex-Vivo 3D Cell Culture System Focused on Oncology Applications
3/26/2012 8:17:37 AM
More...
|
Molecular Response (MRL) Announces Key Agreement in Translational Oncology with OncoMed Pharmaceuticals, Inc.
2/21/2012 8:03:56 AM
More...
|
Transparent Inc. and Molecular Response (MRL) Announce Accelerated Collaborative Research Efforts to Develop Novel 3 Dimensional Cell-Culture Systems for Cancer Research
10/7/2011 9:23:25 AM
More...
|
Molecular Response (MRL) Expands Clinical Offerings with BRAF Mutation Testing
8/18/2011 9:13:46 AM
More...
|
Molecular Response (MRL) Announces Key Agreement in Translational Oncology with SuperGen, Inc. (SUPG)
7/27/2011 10:53:39 AM
More...
|
Molecular Response (MRL) and Scripps Genomic Medicine Announce Joint Discovery/Development Agreement
6/1/2011 9:02:04 AM
More...
|
Molecular Response (MRL) Appoints Kenna Anderes, PhD, as Senior Vice President of Translational Medicine
5/18/2011 9:57:32 AM
More...
|
|